[1] |
LI Shunle, LI Rong, TIAN Yaya, RAN Xiaoli, ZHAO Yanpei, XU Meng.
Association of serum KLF5 and actinin-4 levels with prognosis of TACE treatment for hepatocellular carcinoma
[J]. Basic & Clinical Medicine, 2024, 44(9): 1284-1289.
|
[2] |
ZHENG Hong, CHEN Xiaoxia, HAN Lizhou, CHEN Miao, HUANGFU Juan.
Decrease of lncRNA-RMRP expression inhibits proliferation and invasion of human lung cancer cell line A549
[J]. Basic & Clinical Medicine, 2024, 44(7): 974-978.
|
[3] |
LU Huiying, WANG Jianguo.
Downregulation of demethylase FTO inhibits proliferation of human liver cancer cell line HepG2
[J]. Basic & Clinical Medicine, 2024, 44(2): 185-191.
|
[4] |
LI Jiangli, SUN Jing, TANG Yijun, GUO Junlan, CHEN Bo, GUO Shengnan.
Circ-DDX5 inhibits the proliferation and invasion of human breast cancer cell lines by targeting miR-3940
[J]. Basic & Clinical Medicine, 2024, 44(1): 1-7.
|
[5] |
Yimamaimaitijiang·ABRA, Pakhardin·BAIKERE, YI Chao, TONG Qing.
Clinical value of plasma hsa_circ_005230 in the diagnosis and prognosis evaluation of primary hepatocellular carcinoma
[J]. Basic & Clinical Medicine, 2023, 43(9): 1417-1422.
|
[6] |
LIN Yingxue, CUI Haipeng, WANG Aiguo, YAO Yinhui, ZHAO Juan.
Rapamycin alleviates hepatocellular carcinoma progressing in transgenic mice
[J]. Basic & Clinical Medicine, 2023, 43(8): 1241-1246.
|
[7] |
TANG Yijun, WANG Wenlong, LI Jiangli, YANG Huan, SUN Jing.
LncRNA RP11-686D22.10 is related with the survival of breast cancer patients, affects the proliferation, invasion of breast cancer cell lines
[J]. Basic & Clinical Medicine, 2023, 43(7): 1023-1029.
|
[8] |
JIN Xiaoxia, LU Xiaoyun, LIU Yushan, LIANG Lina.
Expression and clinical significance of SIRT2 in urothelial bladder cancer and its impact on cancer cell proliferation, invasion and migration
[J]. Basic & Clinical Medicine, 2023, 43(7): 1090-1096.
|
[9] |
ZENG Yankun, HONG Xiaoying, CHEN Qinglin.
Down-regulation of BECN1 inhibits the proliferation, invasion and migration of human leukemia cell line THP-1
[J]. Basic & Clinical Medicine, 2023, 43(7): 1104-1109.
|
[10] |
ZOU Jin, HE Xianglei, ZHANG Xin, CHEN Riping, ZHANG Yu, HU Shuaiyue, YING Shibo.
Expression of chemical modification enzymes PADs and PRMTs targeting protein arginine residues in human hepatocellular carcinoma cell lines
[J]. Basic & Clinical Medicine, 2023, 43(6): 898-903.
|
[11] |
JI Mengdie, YUAN Zan, BIAN Xiaocui, YANG Yurong, GUO Xin, WANG Qi, CHEN Yang.
Analysis of genomic copy number variations in human hepatocellular carcinoma cell lines HepG2 and Huh7
[J]. Basic & Clinical Medicine, 2023, 43(6): 960-966.
|
[12] |
LENG Haina, ZHANG Yan, WANG Xiaodong, ZHANG Xueyou, LI Hongli.
miR-767-5p inhibits the invasion of ovarian cancer cell lines by regulating the expression of TBL1XR1 protein
[J]. Basic & Clinical Medicine, 2023, 43(3): 408-414.
|
[13] |
LIU Aixia, ZHANG Hao, SUN Jie, YANG Lihua, ZHAO Xiaotao.
The role of GPS2 in regulating proliferation, migration and invasion of hepatocellular carcinoma cell line MHCC-97H
[J]. Basic & Clinical Medicine, 2023, 43(12): 1784-1791.
|
[14] |
CHA Na, HAO Dandan, LI Tianzhu.
Research progress of microRNAs suppressing tumorigenesis through Hippo signaling
[J]. Basic & Clinical Medicine, 2023, 43(12): 1871-1875.
|
[15] |
HOU Lijie, MA Chengxu, WANG Jingyu, TANG Xulei, FU Songbo.
LncRNA (HOTAIR) /miR-206/TAGLN2 signal axis regulates the invasion of papillarythyroid carcinoma cells
[J]. Basic & Clinical Medicine, 2023, 43(11): 1642-1647.
|